Savonix Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 27
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $2.3M
Latest Deal Amount
  • Investors
  • 14

Savonix General Information

Description

Developer of a virtual neuropsychologist platform designed to assess and monitor cognitive health. The company's platform delivers a mobile, evidence-based assessment of cognitive and emotional function and provides an accurate, accessible, real-time monitoring tool for professional cognitive screening of dementia, enabling healthcare providers to evaluate and leverage results to improve health and treatment outcomes.

Contact Information

Website
savonix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Decision/Risk Analysis
Primary Office
  • 540 Pacific Avenue
  • San Francisco, CA 94133
  • United States
+1 (415) 000-0000

Savonix Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Savonix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 12-Mar-2021 $2.3M 000.00 00.00 Completed Generating Revenue
4. Later Stage VC (Series A1) 04-Sep-2019 000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series A) 25-Apr-2019 00.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Dec-2018 $9.6M $11.1M 000.00 Completed Startup
1. Seed Round 07-Dec-2017 $1.5M $1.5M 00.00 Completed Startup
To view Savonix’s complete valuation and funding history, request access »

Savonix Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A3 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series 4 0,000,000 00.000000 0.000 00.00 00.00 00 00.00 0.000
Series 3 00,000,000 00.000000 0.000 00.00 00.00 00 00.00 00.000
Series 2 6,002,002 $0.000100 0.02% $0.26 $0.26 1x $0.26 4.12%
Series 1 12,600,922 $0.000100 0.02% $0.41 $0.41 1x $0.41 8.64%
To view Savonix’s complete cap table history, request access »

Savonix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a virtual neuropsychologist platform designed to assess and monitor cognitive health. The company's platfor
Other Healthcare Technology Systems
San Francisco, CA
27 As of 2021
000.00
0.00 0000-00-00
00000000000 000.00

00000000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
0000000000 000000000
Bethesda, MD
00 As of 0000
000.00
000 0000-00-00
0000000000 0 000.00

000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000000000000 00000000
Chicago, IL
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Savonix Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BrainScope Venture Capital-Backed Bethesda, MD 00 000.00 0000000000 0 000.00
000000 Venture Capital-Backed Chicago, IL 00 000.00 000000000 - 000.00
000000000 Accelerator/Incubator Backed Toronto, Canada 0 0000 000000000000 0000
0000000 0000000000 Venture Capital-Backed Halifax, Canada 0 0000 000000000000 0000
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
You’re viewing 5 of 13 competitors. Get the full list »

Savonix Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Savonix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190150819-A1 Automated correlation of neuropsychiatric test data Pending 22-Aug-2015 00000000 0
US-10188337-B1 Automated correlation of neuropsychiatric test data Active 22-Aug-2015 00000000

Savonix Executive Team (13)

Name Title Board Seat Contact Info
Mylea Charvat Ph.D Founder & Chief Executive Officer
Pin Chin Kwok Chief Business Officer & President Of Asia-Pacific
Jillian Kwan-Jacobs Chief Operating Officer
Simon Collinson Chief Science Officer
Ellie Hall Chief of Staff
You’re viewing 5 of 13 executive team members. Get the full list »

Savonix Board Members (11)

Name Representing Role Since
David Kim MD digiTx Board Observer 000 0000
Heidi Patel Rethink Capital Partners Board Member 000 0000
John Nackel Ph.D Self Chairman 000 0000
Kyoko Watanabe DEFTA Partners Board Observer 000 0000
You’re viewing 4 of 11 board members. Get the full list »

Savonix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Savonix Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kickstart Ventures Corporate Venture Capital Minority 000 0000 000000 0
Wavemaker Three-Sixty Health Venture Capital Minority 000 0000 000000 0
DEFTA Partners Venture Capital Minority 000 0000 000000 0
digiTx Venture Capital Minority 000 0000 000000 0
Fusion Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial